JAKARTA - 1,620 volunteers will take part in the clinical trial of the COVID-19 Sinovac vaccine candidate. The vaccine test will be conducted at the Padjajaran University Teaching Hospital (RSP), Tuesday, 11 August.
Quoted from Antara, all the volunteer candidates who have registered come from various backgrounds. Volunteer registration is also open to the public.
"There might be volunteers from the ASN. I don't see the status of the volunteers," said Sinovac COVID-19 Vaccine Clinical Research Team Field Manager, Dr. Eddy Fadliyana, Monday, August 10.
Even though it is open to the public, there are several requirements. Volunteers' age must be in the range of 18 to 59 years. They also must be in good health without congenital diseases.
"Actually, it's just the same. Only the examination at the RSP, the swab test takes precedence. The procedure is the same, nothing different. Tomorrow will be the RSP immunization. In other places, it is just the initial stage," said Eddy in Bandung, Monday.
He said that the vaccine test was carried out in six locations, including Unpad Hospital, Dipatiukur Unpad Health Center, Dago Health Center, Sukapakir Health Center, Garuda Health Center, and Ciumbuleuit Health Center.
Directly Reviewed by the President
Health Minister, Terawan Agus Putranto, revealed that President Joko Widodo planned to directly observe the first day of the clinical trial process. The clinical trial of the COVID-19 vaccine will be carried out at the Teaching Hospital (RSP) of Padjajaran University
Terawan Agus Putranto said that during the vaccine injection, everyone must comply with health protocols. For this reason, he directly reviewed the preparation of the vaccine clinical trial prior to President Jokowi's arrival.
"Most importantly, during tomorrow's first vaccine test process, everyone must comply with health protocols. Tomorrow there will be a President who will inspect it," said Terawan at RSP Unpad Jalan Eyckman, Bandung, Monday.
President Jokowi also planned to visit PT Biofarma on Jalan Pasteur, Bandung City.
Among the volunteers who registered, one of them is the Governor of West Java, M Ridwan Kamil. Kang Emil said that he had officially registered himself as a volunteer for the phase three clinical trial of the COVID-19 vaccine from Sinovac, China.
"I have been registered by my health team online. So the online receipt is already there, I will also post that I have registered. I am waiting for announcements from the health side and others. Whether I am feasible and ready to be a volunteer or not. From the registration side, it is already done," said Kang Emil.
The phase three clinical trial of the vaccine requires 1,600 volunteers who live in the Greater Bandung area. Kang Emil hopes that things can run smoothly. With himself registering as a volunteer, he wants to ensure that leaders are involved in direct vaccine testing so that the people are moved to become volunteers.
"Hopefully it will run smoothly, even if it is, I will carry it out according to the procedure. There is no privilege. If I don't become a volunteer, I will announce that there may be health factors," he said.
According to him, a leader who becomes a volunteer will certainly provide a good example to the community. So, there is no term that people are sacrificed by their leaders.
"Everyone is also involved, the governor is also involved in this process," he said.
The English, Chinese, Japanese, Arabic, and French versions are automatically generated by the AI. So there may still be inaccuracies in translating, please always see Indonesian as our main language. (system supported by DigitalSiber.id)